Expand THTX Menu
THTX MENU

THTX Stock Posts


$THTX 21-Oct-22 Straddle Implies a ±34.3% move. Sep 28 Cantor Oncology, Hematology & HemeOnc Conference
Unusual Option Volume

THTX Theratechnologies - Common Shares2.32+0.18 (+8.4%)

Theratechnologies - Common Shares trades 2,327 contracts. THTX will report earnings on Oct 13, 2022. The company has the following event: Cantor Oncology, Hematology & HemeOnc Conference on Sep 28, 2022. News: Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
View Details...
THTX stock increases 79.5% in premarket,

Premarket Gainer

THTX Theratechnologies - Common Shares2.34+0.05+2.2%

Premarket:4.20+1.86 (+79.5%)

Theratechnologies' Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing Cancers

Globe NewswireThu, 4-Feb 7:30 AM
THTX stock increases 24.2% in premarket,

Premarket Gainer

THTX Theratechnologies Inc. - Common Shares2.23-0.03-1.3%

Premarket:2.77+0.54 (+24.2%)

Theratechnologies Reports That Tesamorelin Improves Liver Health

Globe NewswireThu, 23-Jul 4:01 PM
THTX stock increases 66.4% after hours.

After Hours Gainer

THTX Theratechnologies Inc. - Common Shares2.23-0.03-1.3%

After Hours:3.71+1.48 (+66.4%)

Theratechnologies Reports That Tesamorelin Improves Liver Health

Globe NewswireThu, 23-Jul 4:01 PM
THTX stock increases 44.4% in premarket,

Premarket Gainer

THTX Theratechnologies Inc. - Common Shares1.87-0.04-2.1%

Premarket:2.70+0.83 (+44.4%)

New Data Show Theratechnologies' SORT1+ Technology is Effective in Many Treatment-Resistant Cancers

Globe NewswireMon, 22-Jun 7:30 AM
Load Earlier Posts